Moving towards IMPROVED drug-free remission

被引：1

作者：

Bykerk, Vivian P. ^{[1
,2
]}

机构：

[1] Weill Cornell Med Coll, New York, NY 10065 USA

[2] Hosp Special Surg, Inflammatory Arthrit Ctr, 535 E 70th St, New York, NY 10021 USA

来源：

NATURE REVIEWS RHEUMATOLOGY | 2018年 / 14卷 / 04期

基金：

加拿大健康研究院; 美国国家卫生研究院;

关键词：

RHEUMATOID-ARTHRITIS;

D O I：

10.1038/nrrheum.2018.49

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The newly published 5-year outcomes of the IMPROVED trial demonstrate the feasibility of achieving long-term drug-free remission in early rheumatoid arthritis (RA). These findings raise the bar and support the use of a remission induction and maintenance approach, particularly in patients presenting with early joint inflammation consistent with early RA.

引用

页码：193 / 194

页数：2

共 50 条

[21] Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studies
van der Woude, Diane
Visser, Karen
Klarenbeek, Naomi B.
Ronday, H. Karel
Peeters, Andre J.
Kerstens, Pit J. S. M.
Dijkmans, Ben A. C.
Huizinga, Tom W. J.
van der Helm-van Mil, Annette H. M.
Allaart, Cornelia F.
RHEUMATOLOGY, 2012, 51 (06) : 1120 - 1128
[22] Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis
Contreras-Yanez, Irazu
Arturo Guaracha-Basanez, Guillermo
Cuevas-Montoya, Maximiliano
de Jesus Hernandez-Bautista, Jose
Pascual-Ramos, Virginia
ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
[23] Early persistence on therapy impacts drug-free remission: a case-control study in a cohort of Hispanic patients with recent-onset rheumatoid arthritis
Irazú Contreras-Yáñez
Guillermo Arturo Guaracha-Basáñez
Maximiliano Cuevas-Montoya
José de Jesús Hernández-Bautista
Virginia Pascual-Ramos
Arthritis Research & Therapy, 24
[24] Treat to Target (Drug-Free) Inactive Disease in JIA: To What Extent Is This Possible?
Ramanan, Athimalaipet, V
Sage, Anne M.
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
[25] TOFA-PREDICT study protocol: a stratification trial to determine key immunological factors predicting tofacitinib efficacy and drug-free remission in psoriatic arthritis (PsA)
Kleinrensink, Nienke J.
Perton, Frank T.
Pouw, Juliette N.
Vincken, Nanette L. A.
Hartgring, Sarita A. Y.
Jansen, Mylene P.
Arbabi, Saeed
Foppen, Wouter
de Jong, Pim A.
Tekstra, Janneke
Leijten, Emmerik F. A.
Spierings, Julia
Lafeber, Floris P. J. G.
Welsing, Paco M. J.
Heijstek, Marloes W.
BMJ OPEN, 2022, 12 (10):
[26] Drug-free holiday in patients with rheumatoid arthritis: a qualitative study to explore patients’ opinion
I. M. Markusse
G. Akdemir
T. W. J. Huizinga
C. F. Allaart
Clinical Rheumatology, 2014, 33 : 1155 - 1159
[27] Drug-free holiday in patients with rheumatoid arthritis: a qualitative study to explore patients' opinion
Markusse, I. M.
Akdemir, G.
Huizinga, T. W. J.
Allaart, C. F.
CLINICAL RHEUMATOLOGY, 2014, 33 (08) : 1155 - 1159
[28] A new-age for biologic therapies: long-term drug-free therapy with BiP?
Shields, Adrian M.
Panayi, Gabriel S.
Corrigall, Valerie M.
FRONTIERS IN IMMUNOLOGY, 2012, 3
[29] Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics
Teitsma, X. M.
Jacobs, J. W. G.
Concepcion, A. N.
Petho-Schramm, A.
Borm, M. E. A.
van Laar, J. M.
Bijlsma, J. W. J.
Lafeber, F. P. J. G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : 976 - 983
[30] Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combination: insights from systems biology
Xavier M Teitsma
Wei Yang
Johannes W G Jacobs
Attila Pethö-Schramm
Michelle E A Borm
Amy C Harms
Thomas Hankemeier
Jacob M van Laar
Johannes W J Bijlsma
Floris P J G Lafeber
Arthritis Research & Therapy, 20

← 1 2 3 4 5 →